Clinical Trials in Cancer-SMi Conference. 11-12 June 2003, London, UK.
Maneely
Danielle
D
Thomson Current Drugs, London, UK. danielle.maneely@current-drugs.com
D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D000069347:Erlotinib Hydrochloride; D006801:Humans; D015394:Molecular Structure; D009369:Neoplasms / Q000188:drug therapy / Q000517:prevention & control; D011799:Quinazolines / Q000737:chemistry / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; C424962:diflomotecan; D002166:Camptothecin